Legal & General Group PLC Vanda Pharmaceuticals Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 5,317 shares of VNDA stock, worth $26,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,317
Previous 5,317 -0.0%
Holding current value
$26,478
Previous $24,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$4.61 - $6.34 $3,328 - $4,577
722 Added 15.71%
5,317 $24,000
Q2 2024

Aug 14, 2024
SELL
$3.91 - $6.5 $6,592 - $10,959
-1,686 Reduced 26.84%
4,595 $25,000
Q1 2024

Jul 01, 2024
BUY
$3.47 - $4.61 $5,850 - $7,772
1,686 Added 36.69%
6,281 $25,000
Q1 2024

May 14, 2024
SELL
$3.47 - $4.61 $14,927 - $19,832
-4,302 Reduced 48.35%
4,595 $18,000
Q4 2023

Feb 15, 2024
SELL
$3.38 - $4.58 $118,303 - $160,304
-35,001 Reduced 79.73%
8,897 $37,000
Q3 2023

Nov 14, 2023
SELL
$4.28 - $6.57 $472,208 - $724,861
-110,329 Reduced 71.54%
43,898 $189,000
Q2 2023

Aug 14, 2023
BUY
$5.9 - $6.95 $91,886 - $108,239
15,574 Added 11.23%
154,227 $1.02 Million
Q1 2023

May 15, 2023
SELL
$6.18 - $7.99 $9,671 - $12,504
-1,565 Reduced 1.12%
138,653 $941,000
Q4 2022

Feb 14, 2023
BUY
$6.87 - $10.96 $26,353 - $42,042
3,836 Added 2.81%
140,218 $1.04 Million
Q3 2022

Nov 14, 2022
BUY
$9.44 - $11.76 $14,235 - $17,734
1,508 Added 1.12%
136,382 $1.35 Million
Q2 2022

Aug 22, 2022
BUY
$9.31 - $11.84 $11,386 - $14,480
1,223 Added 0.92%
134,874 $1.47 Million
Q1 2022

May 16, 2022
SELL
$10.84 - $16.55 $14,601 - $22,292
-1,347 Reduced 1.0%
133,651 $1.51 Million
Q4 2021

Feb 14, 2022
BUY
$15.69 - $21.14 $73,366 - $98,850
4,676 Added 3.59%
134,998 $2.12 Million
Q3 2021

Nov 15, 2021
BUY
$15.35 - $21.27 $178,213 - $246,944
11,610 Added 9.78%
130,322 $2.23 Million
Q2 2021

Aug 12, 2021
SELL
$15.71 - $21.51 $561,004 - $768,122
-35,710 Reduced 23.12%
118,712 $2.55 Million
Q1 2021

May 17, 2021
BUY
$13.42 - $20.28 $36,462 - $55,100
2,717 Added 1.79%
154,422 $2.32 Million
Q4 2020

Feb 12, 2021
SELL
$9.77 - $13.81 $2,579 - $3,645
-264 Reduced 0.17%
151,705 $1.99 Million
Q3 2020

Nov 13, 2020
BUY
$9.32 - $12.02 $16,831 - $21,708
1,806 Added 1.2%
151,969 $1.47 Million
Q2 2020

Aug 14, 2020
BUY
$9.66 - $12.02 $74,333 - $92,493
7,695 Added 5.4%
150,163 $1.72 Million
Q1 2020

May 14, 2020
BUY
$7.5 - $16.8 $31,320 - $70,156
4,176 Added 3.02%
142,468 $1.48 Million
Q4 2019

Feb 13, 2020
BUY
$12.38 - $17.47 $129,024 - $182,072
10,422 Added 8.15%
138,292 $2.27 Million
Q3 2019

Nov 13, 2019
BUY
$12.27 - $15.79 $41,288 - $53,133
3,365 Added 2.7%
127,870 $1.7 Million
Q2 2019

Aug 14, 2019
BUY
$13.37 - $18.85 $2,861 - $4,033
214 Added 0.17%
124,505 $1.75 Million
Q1 2019

May 15, 2019
BUY
$17.59 - $31.05 $220,596 - $389,398
12,541 Added 11.22%
124,291 $2.29 Million
Q4 2018

Feb 15, 2019
BUY
$18.97 - $31.47 $2,257 - $3,744
119 Added 0.11%
111,750 $2.9 Million
Q3 2018

Nov 20, 2018
BUY
$18.25 - $23.0 $1.89 Million - $2.38 Million
103,561 Added 1283.28%
111,631 $2.56 Million
Q2 2018

Aug 10, 2018
BUY
$13.95 - $19.15 $69 - $95
5 Added 0.06%
8,070 $154,000
Q1 2018

May 17, 2018
SELL
$14.05 - $20.2 $49,596 - $71,306
-3,530 Reduced 30.44%
8,065 $136,000
Q4 2017

Feb 13, 2018
BUY
$12.85 - $18.1 $148,995 - $209,869
11,595
11,595 $176,000

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.3M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $282M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email